Takeda Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Takeda Pharmaceutical Company Limited with three other
companies in this sector in JAPAN :
Eisai Company Limited
sales of 695.62 billion Japanese Yen [US$6.65 billion]
of which 83%
was Pharmaceutical Business),
Astellas Pharma Incorporated
(1.30 trillion Japanese Yen [US$12.44 billion]
of which 97%
was Sales of Pharmaceuticals), and
Daiichi Sankyo Company Limited
(981.79 billion Japanese Yen [US$9.39 billion]
of which 93%
was Prescription drugs).
Takeda Pharmaceutical Company Limited reported sales of ¥3.29 trillion (US$31.46 billion)
March of 2020.
increase of 56.9%
versus 2019, when the company's sales were ¥2.10 trillion.
This was the third consecutive year of growth at Takeda Pharmaceutical Company Limited.